ArticleSensors (Basel, Switzerland)2026
Joint Transmit-Receive Weight Optimization for FDA Radar to Balance Active Detection and RF Stealth.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Existing studies on frequency diverse array (FDA) radar sensing systems have primarily focused on radio-frequency (RF) stealth characteristics with limited attention to the balance between RF stealth and active detection performance. To address this issue, this paper proposes a joint transmit-receive weight optimization scheme for FDA radar systems to achieve an effective balance between active detection and RF stealth. The resulting optimization problem is non-convex, and a block coordinate descent (BCD)-based alternating optimization method with a carefully designed initialization strategy is developed to solve it efficiently. Simulation results demonstrate that the proposed method achieves improved RF stealth performance while maintaining comparable active detection capability, compared with conventional FDA radar and representative existing optimization-based benchmark methods. These results demonstrate the effectiveness of the proposed method for balancing active detection and RF stealth performance in FDA radar sensing systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.